NCT07130097View on ClinicalTrials.gov

A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

August 14, 2025

Primary Completion Date

October 25, 2025

Study Completion Date

November 18, 2025

Conditions
Healthy Participant
Interventions
DRUG

PF-07220060

Cyclin-dependent kinase-4 inhibitor

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT07130097 - A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants | Biotech Hunter | Biotech Hunter